Sign inJoin waitlistJoin the waitlist

Matthew Gubens

HS Clinical Professor · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

Stanford University
2009–2011
Internal Medicine
University of California-San Francisco
2005–2008
Harvard T.H. Chan School of Public Health
Stanford University School of Medicine
2001–2005
Yale University
1993–1997

Research

Pembrolizumab for the treatment of non-small-cell lung cancer
New England Journal of Medicine · 2015 · 5,237 citations
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,255 citations
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
The Lancet Oncology · 2016 · 1,187 citations

James Stevenson
18 papers
Jonathan Riess
17 papers
Joe Chang
16 papers
Christine Lovly
15 papers
Billy Loo
14 papers
Dara Aisner
14 papers
Douglas Wood
13 papers
GR
Gregory Riely
13 papers
Jessica Bauman
13 papers
JL
Jules Lin
13 papers
Michael Lanuti
13 papers
Rudy Lackner
13 papers

Clinical trials

Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer
Principal investigator · Withdrawn · Phase 2
University of California, San Francisco
2020–2023